CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 4 Open-market buy CEO & President bought 5,000 shares at $0.30 ($1,515)
- 4 Open-market buy CEO & President bought 20,000 shares at $0.31 ($6,160)
- 4 Grant or award CEO & President acquired 312,500 shares (grant or award)
- 8-K Event Unregistered share sale · Executive or director change
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Grant or award COO, Secretary, Gen. Counsel acquired 188,679 shares (grant or award)
- 4 Grant or award CEO & President acquired 377,358 shares (grant or award)
- 8-K Event Bylaws or fiscal year change
- SC 13D/A Stake Beneficial Ownership Report
- EFFECT Other Notice of Effectiveness
- 424B5 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SC 13D/A Stake Beneficial Ownership Report
Page 12 of 82 · 1,637 filings